Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...

External beam radiation therapy with or without short-term androgen deprivation showed 15-year survival benefits for ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

The 63-year-old musician revealed his stage 4 prostate cancer diagnosis in November 2022, saying his cancer was “asymptomatic ...

AdvanCell has secured $112 million in a Sanofi Ventures-backed series C funding round as the Australian radiopharma company ...

The study showed the feasibility of simultaneous assessment of tumor-specific responses to multiple drugs to guide targeted systemic therapy for high-risk prostate cancer, reported Benjamin V.

The pharma giant hosted its ninth annual Blue Jacket Fashion Show in collaboration with designer Frederick Anderson in New ...

Medical review of Phase 1 cohorts demonstrated no safety issuesData to be presented at the 10th Annual Innate Killer Summit, March 3-5BOCA RATON, ...

Prostate cancer cells usually require male androgen hormones, such as testosterone, to grow. Androgen deprivation therapy ...

An innovative new prostate cancer treatment is now available at the North Coast Cancer Institute in Lismore, offering significant reductions in ...